Seroprevalence of Hepatitis B and C Viruses and Some Possible Associated Factors Among Cancer Patients at the Oncology Treatment Center, Gondar, Northwest Ethiopia: A Cross-sectional Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Aug 2

PMID 39093829

Authors

Tadesse Atanaw

Getu Girmay

Aragaw Zemene

Muluneh Assefa

Tewodros Eshetie

Gezahegn Bewket

Fikadu Alemiye

Debaka Belete

Nega Birhane

Affiliations

Soon will be listed here.

Abstract

Background: Cancer patients are prone to infections such as hepatitis B virus (HBV) and hepatitis C virus (HCV), which pose a major public health challenge, especially in developing countries. However, little is known about the magnitude of these infections among cancer patients in Ethiopia. Thus, this study determined the prevalence of HBV and HCV in cancer patients at the Oncology Treatment Center, Gondar, Northwest Ethiopia.

Materials And Methods: An institutional-based cross-sectional study was conducted on 115 cancer patients from 15 April to 22 July 2023 at the Oncology Treatment Center, Gondar, Northwest Ethiopia. Sociodemographic, clinical, and other relevant data were collected using a pretested structured questionnaire. Five milliliters of venous blood were collected using a vacutainer tube, serum was harvested and tested for HBV and HCV using a one-step HBsAg and anti-HCV test strip with further confirmation through an ELISA test kit. Data were analyzed using SPSS version 20 and Fisher exact test was used to determine the association between HBV/HCV infection and associated factors.

Results: Out of 115 cancer patients, the majority (62.6%) were females. The median age was 50 (IQR; 40-56) years. The overall prevalence of HBV and HCV infections was 4.3% (95% CI; 0.6-8%) and 6.1% (95% CI; 1.7-10.5%), respectively. Sex was significantly associated with the prevalence of HCV (p = 0.011) with higher anti-HCV positivity in males (14%) than in females (1.4%).

Conclusions: In this study, the prevalence of HCV was higher and the HBV prevalence was intermediate in cancer patients. To reduce the burden of HBV and HCV infections, it is crucial to provide access to HBV and HCV screening services, strengthen vaccination, and improve prompt treatment in cancer patients.

References

Alemu J, Gumi B, Tsegaye A, Abubeker A, Tadesse F, Shewaye A . Frequency of viral infections in adolescent and adult in-patient Ethiopians with acute leukemia at presentation to a tertiary care teaching hospital: a cross-sectional study. Infect Agent Cancer. 2023; 18(1):44. PMC: 10339592. DOI: 10.1186/s13027-023-00519-6. View

Tigabu A, Engda T, Mekonnen F . Seroprevalence of transfusion transmissible viral infections (HIV, HBV and HCV) among voluntary blood donors at University of Gondar Comprehensive Specialized Hospital, Gondar; Northwest Ethiopia. BMC Infect Dis. 2019; 19(1):393. PMC: 6507054. DOI: 10.1186/s12879-019-3950-2. View

Belyhun Y, Maier M, Mulu A, Diro E, Liebert U . Hepatitis viruses in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2016; 16(1):761. PMC: 5168848. DOI: 10.1186/s12879-016-2090-1. View

Luo C, Yu S, Zhang J, Wu X, Dou Z, Li Z . Hepatitis B or C viral infection and the risk of cervical cancer. Infect Agent Cancer. 2022; 17(1):54. PMC: 9624004. DOI: 10.1186/s13027-022-00466-8. View

Asemahagn M . Epidemiology of hepatitis B and C virus infections among patients who booked for surgical procedures at Felegehiwot referral hospital, Northwest Ethiopia. PLoS One. 2020; 15(6):e0234822. PMC: 7299365. DOI: 10.1371/journal.pone.0234822. View

Abera B, Adem Y, Yimer M, Mulu W, Zenebe Y, Mekonnen Z . Community seroprevalence of hepatitis B, C and human immunodeficiency virus in adult population in gojjam zones, northwest Ethiopia. Virol J. 2017; 14(1):21. PMC: 5294870. DOI: 10.1186/s12985-017-0696-6. View

Njiki Bikoi J, Ndedi E, Okobalemba E, Mbaga D, Andre Mbongue Mikangue C, Membangbi A . Seroprevalence of Epstein-Barr virus, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among patients with non-Hodgkin's lymphoma at the Yaounde General Hospital, Cameroon. Pan Afr Med J. 2022; 42:58. PMC: 9307919. DOI: 10.11604/pamj.2022.42.58.31473. View

Chinombe N, Chavhunduka E, Matarira H . Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe. Infect Agent Cancer. 2009; 4:15. PMC: 2764566. DOI: 10.1186/1750-9378-4-15. View

Getie B, Ayalew G, Amsalu A, Ferede G, Yismaw G, Tessema B . Seroprevalence and Associated Factors of Hepatitis B and C Virus Among Pulmonary Tuberculosis Patients Attending Health Facilities in Gondar Town, Northwest Ethiopia. Infect Drug Resist. 2021; 14:3599-3608. PMC: 8423494. DOI: 10.2147/IDR.S327503. View

10.

Tegegne D, Desta K, Tegbaru B, Tilahun T . Seroprevalence and transmission of Hepatitis B virus among delivering women and their new born in selected health facilities, Addis Ababa, Ethiopia: a cross sectional study. BMC Res Notes. 2014; 7:239. PMC: 3991867. DOI: 10.1186/1756-0500-7-239. View

11.

Daia M, Median D, Buinoiu N, Ciocarlan M, Iancu G, Panaitescu A . COVID-19 Pandemic Impact on Cord Blood Collection for Stem Cell Use and Actual Perspectives. Maedica (Bucur). 2021; 16(2):184-188. PMC: 8450644. DOI: 10.26574/maedica.2021.16.2.189. View

12.

Te H, Jensen D . Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010; 14(1):1-21, vii. DOI: 10.1016/j.cld.2009.11.009. View

13.

Ramsey S, Unger J, Baker L, Little R, Loomba R, Hwang J . Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices. JAMA Oncol. 2019; 5(4):497-505. PMC: 6459217. DOI: 10.1001/jamaoncol.2018.6437. View

14.

Razavi H . Global Epidemiology of Viral Hepatitis. Gastroenterol Clin North Am. 2020; 49(2):179-189. DOI: 10.1016/j.gtc.2020.01.001. View

15.

Assefa A, Kiros T, Delelegn B . Seroprevalence and Associated Factors of HBV and HCV among Pregnant Women Attending Antenatal Care at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia: A Cross-Sectional Study. Int J Microbiol. 2023; 2023:2282673. PMC: 10413223. DOI: 10.1155/2023/2282673. View

16.

Li Y, Hu T, Chen W, Hsu P, Chen H . Screening and prevention of hepatitis C virus reactivation during chemotherapy. World J Gastroenterol. 2021; 27(31):5181-5188. PMC: 8384748. DOI: 10.3748/wjg.v27.i31.5181. View

17.

Bakarey A, Jabaru O, Olayiwola O . Seroprevalence of hepatitis B surface antigenemia and viral infectivity among liver cancer patients accessing care at a tertiary health facility in Southwest Nigeria. J Immunoassay Immunochem. 2018; 39(2):196-206. DOI: 10.1080/15321819.2018.1428992. View

18.

Chen C, Hsieh H, Wu T . Real-world prevalence of hepatitis B virus reactivation in cancer patients in Taiwan. J Oncol Pharm Pract. 2020; 27(1):63-70. DOI: 10.1177/1078155220913095. View

19.

Wanyama F, Tauber R, Mokomba A, Nyongesa C, Blanchard V . The Burden of Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses in Ovarian Cancer Patients in Nairobi, Kenya. Infect Dis Rep. 2022; 14(3):433-445. PMC: 9222280. DOI: 10.3390/idr14030047. View

20.

Hsu Y, Huang D, Nguyen M . Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023; 20(8):524-537. DOI: 10.1038/s41575-023-00760-9. View